BTG3 and metastatic carcinoma: As shown in Fig. 1, BTG3 mRNA expression level was higher in ovarian normal tissue and benign tumor, and lower in borderline tumor and primary and metastatic carcinoma (p < 0.05, Fig. 1a, b).